Schaffer David 的 Form 4 申報
4D Molecular Therapeutics, Inc.（FDMT），2021/9/29 申報
- 申報編號
- 0001567619-21-017624
- 申報時間
- 2021/9/29
- 交易日
- 2021/9/27-9/28
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 5 筆非衍生性交易。公開市場賣出合計 $106.1 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Schaffer DavidCIK 0001692929 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/9/27 | Common Stock | S賣出處分 | −13,075 | $32.59F2 | −$426,114.25 | 986,925 | 直接 | |
| 2021/9/27 | Common Stock | S賣出處分 | −6,157 | $33.51F4 | −$206,321.07 | 980,768 | 直接 | |
| 2021/9/27 | Common Stock | S賣出處分 | −100 | $34.19 | −$3,419 | 980,668 | 直接 | |
| 2021/9/28 | Common Stock | S賣出處分 | −13,812 | $30.52F5 | −$421,542.24 | 966,856 | 直接 | |
| 2021/9/28 | Common Stock | S賣出處分 | −100 | $32.00 | −$3,200 | 966,756 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The transaction was executed in multiple trades in prices ranging from $32.09 to $33.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The transaction was executed in multiple trades in prices ranging from $33.10 to $34.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The transaction was executed in multiple trades in prices ranging from $30.28 to $31.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。